AVZO-023

Avenzo begins Phase I/II trial of CDK4 selective inhibitor for breast cancer
Clinical Trials Arena
Fri, 06/6/25 - 12:03 pm
Avenzo Therapeutics
AVZO-023
breast cancer
clinical trials